Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 348

1.

The role of transdermal buprenorphine in the treatment of cancer pain: an expert panel consensus.

Pergolizzi JV Jr, Mercadante S, Echaburu AV, Van den Eynden B, Fragoso RM, Mordarski S, Lybaert W, Beniak J, Orońska A, Slama O; Euromed Communications meeting.

Curr Med Res Opin. 2009 Jun;25(6):1517-28. doi: 10.1185/03007990902920731.

PMID:
19435402
[PubMed - indexed for MEDLINE]
2.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
[PubMed - indexed for MEDLINE]
3.

Transdermal buprenorphine in cancer pain and palliative care.

Sittl R.

Palliat Med. 2006;20 Suppl 1:s25-30. Review.

PMID:
16764218
[PubMed - indexed for MEDLINE]
4.
5.

Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.

Likar R, Lorenz V, Korak-Leiter M, Kager I, Sittl R.

Clin Ther. 2007 Aug;29(8):1591-606.

PMID:
17919542
[PubMed - indexed for MEDLINE]
6.

Transdermal buprenorphine in clinical practice--a post-marketing surveillance study in 13,179 patients.

Griessinger N, Sittl R, Likar R.

Curr Med Res Opin. 2005 Aug;21(8):1147-56.

PMID:
16083522
[PubMed - indexed for MEDLINE]
7.

[Transdermal buprenorphine for treatment of chronic tumor and non-tumor pain].

Likar R, Griessinger N, Sadjak A, Sittl R.

Wien Med Wochenschr. 2003;153(13-14):317-22. German.

PMID:
12924108
[PubMed - indexed for MEDLINE]
8.

Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine.

Kress HG.

Eur J Pain. 2009 Mar;13(3):219-30. doi: 10.1016/j.ejpain.2008.04.011. Epub 2008 Jun 24. Review.

PMID:
18567516
[PubMed - indexed for MEDLINE]
9.
11.

Buprenorphine 5, 10 and 20 μg/h transdermal patch: a review of its use in the management of chronic non-malignant pain.

Plosker GL.

Drugs. 2011 Dec 24;71(18):2491-509. doi: 10.2165/11208250-000000000-00000. Review.

PMID:
22141389
[PubMed - indexed for MEDLINE]
12.

Pediatric palliative care: use of opioids for the management of pain.

Zernikow B, Michel E, Craig F, Anderson BJ.

Paediatr Drugs. 2009;11(2):129-51. doi: 10.2165/00148581-200911020-00004. Review.

PMID:
19301934
[PubMed - indexed for MEDLINE]
13.
14.

Responsible prescribing of opioids for the management of chronic pain.

Nicholson B.

Drugs. 2003;63(1):17-32. Review.

PMID:
12487620
[PubMed - indexed for MEDLINE]
16.

Opioids switching with transdermal systems in chronic cancer pain.

Aurilio C, Pace MC, Pota V, Sansone P, Barbarisi M, Grella E, Passavanti MB.

J Exp Clin Cancer Res. 2009 May 7;28:61. doi: 10.1186/1756-9966-28-61.

PMID:
19422676
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Transdermal buprenorphine in the treatment of chronic pain.

Sittl R.

Expert Rev Neurother. 2005 May;5(3):315-23. Review.

PMID:
15938664
[PubMed - indexed for MEDLINE]
18.

Opioid rotation from high-dose morphine to transdermal buprenorphine (Transtec) in chronic pain patients.

Freye E, Anderson-Hillemacher A, Ritzdorf I, Levy JV.

Pain Pract. 2007 Jun;7(2):123-9.

PMID:
17559481
[PubMed - indexed for MEDLINE]
19.
20.

Transdermal buprenorphine in pain management--experiences from clinical practice: Five case studies.

Louis F.

Int J Clin Pract. 2006 Oct;60(10):1330-4.

PMID:
16981980
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk